openserveblockversewordysbillionaire.aiyourlistWhiteboardAppquizieunschool

News

Discover

Markets

openserveblockversewordysbillionaire.aiyourlistWhiteboardAppquizieunschool

Bavarian Nordic — news, coverage & facts — IJR

|NewsJournalsOrganizationBavarian Nordic

Bavarian Nordic — Unknown authorUnknown author · Public domain

Organization

Bavarian Nordic

Danish vaccine manufacturing company

0 members

Feed News Media Community Answers Map About

1 mentions · 24hcoverage spread: L0/C100/R0

Comments

Ask this entity anything:

Free account · your comment posts right after signup

Photo: SHVETS production / Wikimedia Commons (Pexels)
Finance
Bavarian Nordic Q2 Revenue Surges, 2026 Outlook Upgraded
Bavarian Nordic posted a strong Q2 2026 with revenue about 2.03 billion DKK and EBITDA of roughly 925 million, lifting full-year guidance to around 5.7 billion DKK and targeting an EBITDA margin near 30%. The firm highlighted record Travel Health revenue, robust demand for rabies and chikungunya vaccines, a new 750 million DKK share buy-back, and updated Public Preparedness outlook alongside a revised Vimkunya sales view for 2026.
6 sources

Facts from Wikidata (CC0). Image via Wikimedia Commons (Public domain).

Bavarian Nordic A/S is a Danish biotechnology company focused on the development, manufacturing and commercialization of vaccines. The company is headquartered in Hellerup, Denmark, with manufacturing facilities in Kvistgård, Denmark and Thörishaus near Bern, Switzerland. The company has research and development facilities in Martinsried, Germany, as well as offices in USA, Canada, and France. The company uses viral vectors and virus-like particles in its research and development.

Read the full article →

Country: Denmark
Headquarters: Hellerup
Inception: July 1, 1992
Website: https://www.bavarian-nordic.com

Related

Paul Chaplinchief executive Arbejdsmarkedets Tillægspensionowner Denmarkcountry Gentofte Municipalitylocated in